What if a soft material could move on its own, guided not by electronics or motors, but by the kind of rudimentary chemical ...

Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...

As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop ...

This systematic review and meta-analysis found that while yogurt consumption shows a modest positive association with bone ...

Researchers have developed the world’s first flow battery powered by glucose and vitamin B2, mimicking the human body’s ...

(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...

Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with ...

Wellness purchases are now treated more like scientific procurement than regular shopping. Buyers look for data, authenticity ...

Watch parts 1, 2, and 3 of our conversation with Dr Collins.

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today announced that it will present new clinical data from its Phase 2 trial of EB613 at ...

Nanopore sensors enable precise protein and peptide analysis, crucial for early disease diagnosis and advancing personalized healthcare solutions.